- Home
- EVOK
EVOK
Evoke Pharma Inc.
as 11-25-2025 12:16pm EST
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | 18.4M | IPO Year: | 2013 |
| Target Price: | N/A | AVG Volume (30 days): | 246.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.88 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.94 - $10.86 | Next Earning Date: | 11-13-2025 |
| Revenue: | $14,424,652 | Revenue Growth: | 67.40% |
| Revenue Growth (this year): | 57.38% | Revenue Growth (next year): | 59.57% |
Stock Insider Trading Activity of Evoke Pharma Inc. (EVOK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Klein Roger M. | EVOK | 10% Owner | Nov 6 '25 | Sell | $10.65 | 9,000 | $95,885.00 | 29,000 |
Latest Evoke Pharma Inc. News
EVOK Breaking Stock News: Dive into EVOK Ticker-Specific Updates for Smart Investing
GlobeNewswire
13 days ago
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Simply Wall St.
14 days ago
UK Growth Companies With High Insider Ownership In November 2025
MT Newswires
22 days ago
Top Midday Gainers
MT Newswires
22 days ago
Investors Digest Earnings, Driving Premarket Losses for US Equity Futures
MT Newswires
22 days ago
Top Premarket Gainers
GlobeNewswire
22 days ago
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Simply Wall St.
3 months ago
UK Growth Stocks With Strong Insider Ownership
Simply Wall St.
5 months ago
Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK)
Compare EVOK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EVOK Evoke Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.